Cancer AI Models Will Reach Clinical Trials Within a Year | Tanishq Abraham
Tanishq Abraham, co-founder and CEO of Sophont, discusses the launch of Holon-S1, an AI model trained on pathology tissue slides that extracts deep molecular and biological insights directly from standard tumor biopsies. He explains how AI enables hyper-personalized cancer care, maps tumor biology for rare cancers like osteosarcoma, and can accelerate clinical trials by grounding bio-AI models directly in human clinical data. Check out our sponsor Lovable: https://lovable.dev. Turn ideas into software people love.
https://x.com/iScienceLuvr
--
MTS is a live news and interview show covering…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.